Vigilant Biosciences Inc. of Fort Lauderdale, FL at MEDICA 2019 in Düsseldorf -- MEDICA - World Forum for Medicine
Manage stand orders
Select Option

Vigilant Biosciences Inc.

5301 NW 5th Way, 33309 Fort Lauderdale, FL

This company is co-exhibitor of
Enterprise Florida Inc.

Hall map

MEDICA 2019 hall map (Hall 16): stand C02

Fairground map

MEDICA 2019 fairground map: Hall 16

Our range of products

Product categories

  • 03  Diagnostic Tests
  • 03.07  Other diagnostics

Other diagnostics

Our products

Product category: Other diagnostics

Vigilant Biosciences®

Our products empower healthcare professionals and improve potential outcomes by aiding in the early diagnosis of oral cancer (including oral and oropharyngeal cancer).

Vigilant Biosciences® products are based on advanced patented technology, including an innovative methodology for measuring total protein levels and assessing the level of tumor-initiating and stem cell-associated biomarker CD44 that, together with other clinical factors, can aid clinicians in the early detection and intervention of oral cancer. These clinically validated tests enable early and accurate detection of oral cancer, potentially even before visual or physical indicators.

This foundational science leverages nearly two decades of clinical research conducted by Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine.

More Less

About us

Company details

Vigilant Biosciences® is dedicated to helping create a world where cancer doesn’t stand a fighting chance.

Vigilant Biosciences is a leading innovator and developer of solutions that aid in the early detection and intervention of cancer. Our point-of-care and lab-based solutions are simple, accurate and cost-effective – empowering healthcare practitioners to improve potential outcomes through earlier intervention.

Vigilant Biosciences products are based on patented technology that detects specific protein markers clinically shown to be associated with early stage cancers, potentially even prior to visual or physical indicators. The Vigilant Biosciences product line currently includes the OncAlertT  Oral Cancer RAPID Test which is CE Marked and available in select markets outside the United States.

More Less